Oligometastatic Disease
specificA finding of a malignant solid neoplasm that has metastasized to a limited number of sites-existing in a state intermediate between localized disease and widespread metastatic disease.
10
Centers
4
Active Trials
$37K
Cancer Funding
Top Centers for Oligometastatic Disease(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 66.8 |
| 2 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 66.8 |
| 3 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 66.8 |
| 4 | BC CancerVancouver, BC Active Research Program | 66.8 |
| 5 | UMass Memorial Health Cancer CenterWorcester, MA Active Research Program | 61.7 |
| 6 | NCI Comprehensive | 44.2 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 44.2 |
| 8 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 44.2 |
| 9 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 44.2 |
| 10 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 44.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →